GSK, Vir Biotech seek emergency use authorisation for COVID-19 antibody
Companies are requesting emergency approval of drug for the early treatment of COVID-19
Read More
Tag: Vir Biotechnology
GSK, Vir look beyond COVID-19 to develop new therapies for flu and other respiratory viruses
New agreement builds on existing collaboration to develop therapies for coronaviruses
Read More
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
Companies will collaborate on a combination therapy study
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
